• 15 June 2015

    Join MBA Programs at GISMA Business School, Germany

    GISMA Business School, located in the heart of Hannover, Germany, is an international Business School offering campus-based business education to students from over 40 countries.
    GISMA Business School is closely affiliated with Global University Systems (GUS), a consortium of 8 educational institutions, and is internationally accredited by AMBA. All courses at GISMA are taught in English, as the world’s foremost language for business and global communication. Our alumni come from as many as 40 different nations and are taught by professors of diverse cultural backgrounds.

    ENQUIRE NOW >>

    Our AMBA-accredited Programmes

    1) MBA:
    Become more than a business leader. Become a leader with a global viewpoint and practical experience – and an MBA from two highly regarded European business schools.
    International Track, 18 months / Fast-Track, 12 months / Part-Time, 24 months

    2) Masters in Management in International Business:
    Become a leader with a Master degree from two highly regarded European business schools.
    Full-Time, 12 months

    Program Highlights
    Flexible and career enhancing programmes that paves the way for a career in management.

    Eligibility: Graduates, Postgraduates

    ENQUIRE NOW >>

  • 8 June 2015
    Advertisement for Junior Research Fellow in CUR | M.Pharm

    Applications are invited for the post of Junior Research Fellow on purely temporary basis to work on the DST-sponsored research project to be undertaken at the Department of Pharmacy, Central University of Rajasthan.

    Post: Junior Research Fellow (JRF) - 01

  • 3 June 2015
    Faculty positions in Shekhawati College of Pharmacy

    The Shekhawati College of Pharmacy, being started from the academic year 2006-2007, in an institution which is to provide the professional program for the Bachelor Degree in Pharmacy (B. Pharma) being started from the academic year 2006-2007 in the region. The holder of this degree will practice a profession, which besides being highly dignified, leads to the additional satistafaction of serving the ailing humanity The College is located in the serene environment away from the hustle and bustle of the urban atmosphere It provides excellent peaceful atmosphere for studies. The students are provided with excellent hostel facilities on the campus itself. Besides, wide ranging provisions are available for extracurricular activities.

    Post: Faculty positions

  • 1 June 2015
    PharmaTutor Magazine - June 2015 is released | Read online or Subscribe

  • 24 May 2015
    Recruitment of Non-Official Director in Rajasthan Drugs and Pharmaceuticals Limited

    RAJASTHAN DRUGS AND PHARMACEUTICALS LIMITED is a Central Public Sector Enterprise with equity participation by Govt. of Rajasthan through RIICO Ltd. (Govt. of India 51% and RIICO Ltd. 49%). The Company invites offers from individuals for consideration for appointment of Independent Directors on its Board of Directors as per guidelines issued by Department of Public Enterprises, Govt. of India.

    CRITERIA LAID DOWN FOR CONSIDERATION AS NON-OFFICIAL DIRECTOR.

    Post: Non-Official Director

  • 20 May 2015
    Faculty - Paramedical Lecturer / Professor in Client of 7 Colors Consultants

    Our Client is one of the leader in Health Care /Medical Industry

    Post: Faculty - Paramedical Lecturer / Professor

  • 14 May 2015
    Career as Area Business Manager in Jenome Biophar

    We, Jenome Biophar recognize itself as a business organization with a mission, not merely an entity that exists to generate profit. This mission describes the road map towards reaching long-term objectives and establishing the organization's future vision. Moreover, it highlights the basis and values that control business conduct on all levels.
    Moreover, a clear future vision accessible to all company employees is an important element in portraying the desired shape of the organization in the future and therefore inspires, motivates and improves performance. This is why we keep our mission and vision in mind and heart at all times.
    We, Jenome Oncology, are dedicated to anticancer range of products. We are dealing in almost all chemotherapeutic range of products as well as we also deal in unique & specialized anti cancer range of products. We are the pioneer in our special range of products which we had launched first time in India.

    Post: Area Business Manager

  • 30 April 2015
    PharmaTutor Magazine - May 2015 is released | Read online and Subscribe

  • 26 April 2015
    MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3
    1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
    2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
    3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
    sureshrewar1990@gmail.com

    ABSTRACT
    A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.

  • 24 April 2015
    MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

    ABOUT AUTHORS:
    Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3
    1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
    2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
    3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
    sureshrewar1990@gmail.com

    ABSTRACT
    A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.

Subscribe to Rajasthan